This meta-analysis synthesizes current data from 30 specialized sources regarding Empty Nose Syndrome (ENS). It describes a complex iatrogenic condition characterized by a profound disconnect between anatomical patency and functional sensation, typically occurring after aggressive turbinate resection.

1. Pathophysiology: The Paradox of Airflow and Sensation

ENS is fundamentally an aerodynamic and neurosensory disorder where "more room" in the nose results in "less air" perceived by the patient.

• Aerodynamic Alterations (CFD): Computational Fluid Dynamics (CFD) reveals that ENS patients have significantly lower nasal resistance (approximately 25.7% lower) and larger cross-sectional areas than healthy subjects. Paradoxically, air does not circulate efficiently; it forms a narrow jet toward the middle meatus, largely bypassing the inferior meatus. This results in high velocities (9–15 m/s compared to 6–8 m/s in healthy individuals) and the formation of vortices (eddies) in the inferior meatus, which contribute to mucosal dryness and crusting.
• Air Conditioning Deficit: Without functional turbinates, inspired air is poorly warmed and humidified. Air reaching the cavum is significantly colder (24–30°C) than in healthy subjects (30–32°C), which is believed to trigger the paradoxical sensation of obstruction.
• Neurosensoriel Dysfunction: There is a marked loss of trigeminal sensitivity. Patients exhibit significantly altered Menthol Lateralization Detection Thresholds (LDT), indicating damage to TRPM8 cold receptors. Reduced Wall Shear Stress (WSS) in the inferior meatus is directly correlated with clinical scores for "suffocation" and "nose feels too open".

2. Diagnostic Tools and Biomarkers

Diagnosis relies on a combination of validated subjective scales and emerging objective markers:

• Validated Questionnaires: The ENS6Q (a score ≥ 11 is indicative), SNOT-22/25, and the NOSE scale are the clinical standards.
• Nasal Nitric Oxide (nNO): nNO levels are significantly lower in ENS patients compared to healthy controls. An increase in nNO following surgical treatment is a powerful biomarker for psychiatric recovery, correlating with reduced scores on the Beck Depression Inventory (BDI-II) and Beck Anxiety Inventory (BAI).
• Functional Imaging (fMRI): fMRI studies demonstrate that ENS patients process nasal patency differently, showing prominent activation in limbic system areas associated with emotional distress and "air hunger" even at rest.

3. Therapeutic Strategies

Current research explores three major axes for management:

• Surgical Rehabilitation: The goal is to reduce nasal volume and normalize airflow using submucosal implants (e.g., Medpor, autologous cartilage, Alloderm). Virtual surgery via CFD demonstrates that these implants can successfully correct vortices, increase WSS, and restore air-warming capabilities.
• Regenerative Medicine: Techniques using Adipose-Derived Stem Cells (ADSC) or Stromal Vascular Fraction (SVF) aim to functionally reconstruct the mucosa. SVF injections have been shown to significantly decrease inflammatory cytokines (IL-1β, IL-8), although clinical symptom improvement varies. ADSCs combined with fat granules can improve mucociliary clearance and ciliary alignment.
• Conservative Care: "Trigeminal training" involving daily inhalations of menthol and eucalyptol can improve the perception of nasal patency by stimulating remaining TRPM8 receptors.

4. Psychiatric Impact and Quality of Life

ENS is associated with extreme psychological distress, including high anxiety, depression, chronic fatigue, and suicidal ideation. fMRI confirms a neurological substrate for this suffering; menthol inhalation has been shown to alleviate distress by decreasing the activation of paralimbic temporal pole areas.

Conclusion of the Meta-Analysis

ENS research is currently dominated by case series and observational studies (Level 4 evidence), with a significant need for randomized controlled trials. The future of management lies in a personalized approach using CFD to plan "tailor-made" surgeries and integrating objective biomarkers like nNO to monitor both physical and psychological recovery.